Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.
Bsteh G, Hoepner R, Gernert JA, Berek K, Gradl C, Kliushnikova D, Damulina A, Traxler G, Föttinger F, Habernig S, Krajnc N, Betancourt AXL, Ponleitner M, Zrzavy T, Deisenhammer F, Di Pauli F, Havla J, Khalil M, Kümpfel T, Wipfler P, Chan A, Berger T, Hammer H, Hegen H. Bsteh G, et al. Among authors: berger t. Eur J Neurol. 2025 Jan;32(1):e16587. doi: 10.1111/ene.16587. Eur J Neurol. 2025. PMID: 39686558 Free PMC article.
Multiple sclerosis and COVID-19: How many are at risk?
Bsteh G, Bitschnau C, Hegen H, Auer M, Di Pauli F, Rommer P, Deisenhammer F, Berger T. Bsteh G, et al. Among authors: berger t. Eur J Neurol. 2021 Oct;28(10):3369-3374. doi: 10.1111/ene.14555. Epub 2020 Oct 22. Eur J Neurol. 2021. PMID: 32978860 Free PMC article.
Decision making and framing effects in multiple sclerosis.
Zamarian L, Berger T, Pertl MT, Bsteh G, Djamshidian A, Deisenhammer F, Delazer M. Zamarian L, et al. Among authors: berger t. Eur J Neurol. 2021 Apr;28(4):1292-1298. doi: 10.1111/ene.14669. Epub 2020 Dec 27. Eur J Neurol. 2021. PMID: 33296528 Free PMC article.
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Bsteh G, Hegen H, Riedl K, Altmann P, Auer M, Berek K, Di Pauli F, Ehling R, Kornek B, Monschein T, Rinner W, Schmied C, Wurth S, Zebenholzer K, Zinganell A, Zrzavy T, Zulehner G, Deisenhammer F, Rommer P, Leutmezer F, Berger T. Bsteh G, et al. Among authors: berger t. Eur J Neurol. 2021 May;28(5):1609-1616. doi: 10.1111/ene.14705. Epub 2021 Jan 18. Eur J Neurol. 2021. PMID: 33370478 Free PMC article.
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Leutmezer F, Rommer P, Wurth S, Zinganell A, Zrzavy T, Deisenhammer F, Berger T. Bsteh G, et al. Among authors: berger t. Eur J Neurol. 2021 Jun;28(6):2037-2045. doi: 10.1111/ene.14829. Epub 2021 Apr 2. Eur J Neurol. 2021. PMID: 33735479 Free PMC article.
Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study.
Bsteh G, Hegen H, Traxler G, Krajnc N, Leutmezer F, Di Pauli F, Kornek B, Rommer P, Zulehner G, Dürauer S, Bauer A, Kratzwald S, Klotz S, Winklehner M, Deisenhammer F, Guger M, Höftberger R, Berger T. Bsteh G, et al. Among authors: berger t. Eur J Neurol. 2022 May;29(5):1538-1544. doi: 10.1111/ene.15265. Epub 2022 Feb 9. Eur J Neurol. 2022. PMID: 35102646 Free PMC article.
2,142 results